X4 Pharmaceuticals (XFOR) Selling, General & Administrative (2017 - 2026)
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 3.41 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -2.87 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 110.21 Mn |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 593.21 Mn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 351.74 Mn |
| 10 | X4 Pharmaceuticals | 510.43 Mn | 315.33 Mn | 7.19 Mn | 8.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.50 Mn |
| Mar 31, 2026 | 6.97 Mn |
| Dec 31, 2025 | 7.38 Mn |
| Sep 30, 2025 | 11.59 Mn |
| Jun 30, 2025 | 9.53 Mn |
| Mar 31, 2025 | 15.02 Mn |
| Dec 31, 2024 | 15.15 Mn |
| Sep 30, 2024 | 15.66 Mn |
| Jun 30, 2024 | 13.28 Mn |
| Mar 31, 2024 | 17.44 Mn |
| Dec 31, 2023 | 9.93 Mn |
| Sep 30, 2023 | 8.13 Mn |
| Jun 30, 2023 | 10.20 Mn |
| Mar 31, 2023 | 7.24 Mn |
| Dec 31, 2022 | 6.56 Mn |
| Sep 30, 2022 | 6.04 Mn |
| Jun 30, 2022 | 6.75 Mn |
| Mar 31, 2022 | 7.66 Mn |
| Dec 31, 2021 | 7.14 Mn |
| Sep 30, 2021 | 5.93 Mn |